Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Patrick K. Reville"'
Autor:
Rebecca S. S. Tidwell, Sa A. Wang, Naval Daver, Musa Yilmaz, Yesid Alvarado, Farhad Ravandi, Tapan M. Kadia, Courtney D. DiNardo, Naveen Pemmaraju, Guillermo Garcia-Manero, Nitin Jain, Nicholas J. Short, Steven M. Kornblau, Gautam Borthakur, Rabiul Islam, Hagop M. Kantarjian, Patrick K. Reville, Marina Konopleva
Publikováno v:
Lancet Haematol
Summary Background Addition of the BCL2 inhibitor venetoclax to lower intensity therapy has been shown to improve overall survival in older (aged 75 years or older) and unfit patients with newly diagnosed acute myeloid leukaemia. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d51d3854846c1936e9e71a1b7fa758e
https://europepmc.org/articles/PMC8884174/
https://europepmc.org/articles/PMC8884174/
Autor:
Courtney D. DiNardo, Maro Ohanian, Zeev Estrov, Patrick K. Reville, Prithviraj Bose, Sa A. Wang, Michael Andreeff, Farhad Ravandi, Musa Yilmaz, Naval Daver, Lucia Masarova, Hagop M. Kantarjian, Tapan M. Kadia, Yesid Alvarado, Guillermo Garcia-Manero, Nicholas J. Short, Rebecca S. S. Tidwell, Guillermo Montalban-Bravo, Nitin Jain, Gautam Borthakur, Elias Jabbour, Steven M. Kornblau, Marina Konopleva
Publikováno v:
Blood. 136:7-9
Background Addition of the BCL2 inhibitor venetoclax to lower intensity therapy improved survival (OS) for older and unfit patients with newly diagnosed AML. We have previously reported the safety and efficacy of the nucleoside analogue cladribine co
Autor:
Elias Jabbour, Koichi Takahashi, Kapil N. Bhalla, Guillermo Garcia-Manero, Rashmi Malla, Naval Daver, Caitlin R. Rausch, Naveen Pemmaraju, Nitin Jain, Farhad Ravandi, Uday R. Popat, Marina Konopleva, Patrick K. Reville, Michael Andreeff, Hagop M. Kantarjian, Maro Ohanian, Guillermo Montalban-Bravo, Gautam Borthakur, Kelly Marek, Nicholas J. Short, Koji Sasaki, Alessandra Ferrajoli, Ghayas C. Issa, Tapan M. Kadia, Mark Brandt, Courtney D. DiNardo
Publikováno v:
Blood. 138:367-367
Background The combination of venetoclax and 5-azacytidine (5-AZA) for older and unfit patients with newly diagnosed AML has led to significant improvements in remission rates and survival compared to 5-AZA alone. We previously reported encouraging r
Autor:
Ken M. Riedl, Gregory B. Lesinski, Yael Vodovotz, Elizabeth Grainger, Courtney Nicholas, Thomas A. Mace, Patrick K. Reville, Jennifer Ahn-Jarvis, Gregory S. Young, Matthew A. Bill, Steven K. Clinton, Steven J. Schwartz
Publikováno v:
Cancer Research. 73:162-162
Soybeans are a rich source of bioactive phytochemcials. Among the phytochemicals, the isoflavones (primarily genistein and daidzein) have received the greatest attention regarding cancer prevention. Indeed, we and others have reported dietary soy has